• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30

Prodisc® Total Disc Replacement from Centinel Spine® Grows 38% in Full-Year 2024, Setting a New Revenue Record in the Fourth Quarter

Category: Press Releases
Match-the-Disc Portfolio
Pin It

Centinel Spine®, LLC  the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced achievement of record fourth quarter and full-year 2024 business results, positioning the Company for continued accelerated growth in 2025.

Centinel Spine continues as one of the leading growth companies in the spine industry2 and is dedicated exclusively to total disc replacement, one of the fastest growing segments in orthopedic implants. The Company remains well-positioned from a profitability perspective, achieving record EBITDA positive performance in the fourth-quarter and full-year 2024.1

Fourth Quarter 2024 Highlights

    Record worldwide prodisc TDR revenue of nearly $30 million, representing 47% year-over-year (YOY) growth.
    Record worldwide prodisc Cervical revenue of almost $17 million, a 38% YOY increase, and prodisc Lumbar revenue of nearly $13 million, up 62% YOY.
    Record U.S. prodisc TDR revenue of over $25 million, up 52% YOY.
    International prodisc TDR revenue of $4.6 million, up 27% YOY.

Full-Year 2024 Highlights

    Record worldwide prodisc TDR revenue of over $95 million, a 38% YOY increase.
    Record worldwide prodisc Cervical revenue of over $59 million, up 39% YOY.
    Record worldwide prodisc Lumbar revenue of nearly $36 million, up 35% YOY.
    Record U.S. prodisc TDR revenue of nearly $77 million, up 41% YOY.
    Record U.S. prodisc total surgeon user-base of over 1,100 surgeons, a 44% YOY increase.
    Over 1,000 U.S. healthcare facilities used prodisc, a YOY increase of 28%.
    Record International prodisc TDR revenue of over $18 million, representing growth of 24% YOY.

Highlights on the New Match-the-Disc™ prodisc Cervical TDR System

    Over 9,000 procedures completed with the new system in the U.S. through the end of 2024, after limited release in Q3 2022.
    The new system drove a 46% increase in full-year 2024 U.S. prodisc Cervical revenue.
    Added an average of over 100 new surgeon users per quarter to the Match-the-Disc system in 2024, increasing the total number of surgeons using the new prodisc Cervical system to over 900.
    Strong majority of new surgeon users came from competitive conversions and remain repeat users.

Centinel Spine CEO Steve Murray adds, "The Centinel Spine team achieved records in all aspects of our global business in 2024.  We are exclusively committed to total disc replacement, with the goal of becoming the clear global leader in this fast-growing segment of the spine market. The prodisc technology not only offers the benefits of our "Match-the-Disc" innovation, it is coupled with the longest demonstrated history of clinical success in disc replacement.  We are all-in on total disc replacement and well-positioned for continued success in 2025 and beyond."

For more information, please visit www.CentinelSpine.com

Company Name: Centinel Spine, LLC
About Company: Centinel Spine®, LLC is the leading global medical device company exclusively focused on addressing cervical and lumbar spinal disease with prodisc®, the most complete total disc replacement (TDR) technology platform in the world. The Company's prodisc technology is the most studied and clinically-proven TDR system across the globe, validated by over 540 published papers and more than 275,000 implantations. Centinel Spine's prodisc is the only TDR technology with multiple motion-preserving anatomic solutions, allowing the surgeon to Match-the-Disc™ to each patient's anatomy for both cervical and lumbar total disc replacement.